Enavail To Build New cGMP Facility

Enavail, LLC, a particle engineering company has plans to build a new cGMP facility in the Abilene Life Sciences Accelerator (ALSA). The facility is designed to enhance drugs with poor water solubility, which can limit a drug’s effectiveness.

Using its lab in Austin and the planned cGMP facility in Abilene, Enavail will work with partners to provide improved formulations, product development and clinical scale manufacturing. The 1,800-sq.-ft. facility will be built in compliance with cGMP and will support clinical batch production and commercial scale manufacturing. The facility is expected to be complete in September.

“The strategic decision to build our new cGMP facility in Abilene was based on a thorough review of our options,” said Brian Windsor, Ph.D., president of Enavail. “The space and the services the Abilene Life Sciences Accelerator have to offer are a perfect fit for us. They will allow for ongoing support for our clients’ clinical and commercial GMP needs. We presently offer phase I cGMP clinical batch production for compounds with applications in pulmonary, parenteral, intranasal and oral delivery. The Abilene facility will allow us to support all clinical phases as well as commercial manufacturing.”